Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.

Cardiovascular research - 15 Feb 2006

Ye Shu

Abstract excerpt

Data have been accumulating that indicate that matrix metalloproteinase (MMP) gene polymorphisms contribute to inter-individual differences in susceptibility to and outcome of cardiovascular disease. This is currently best exemplified by the MMP3 gene 5A/6A polymorphism which has an effect on MMP3 expression and has been shown to be associated with coronary stenosis, myocardial infarction, coronary artery...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Matrix Metalloproteinases
Share to Cardiovascular Diseases
Share to Cardiovascular System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to MMP12 gene

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Heterozygote

Share to Treatment Outcome

Source

Identifiers

PMID: 16122719
DOI: 10.1016/j.cardiores.2005.07.015

Genes

MMP3
MMP1
MMP12
MMP13
MMP2
MMP7
MMP9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.PMID 16122719Read ↗

A role for MMP-3 genetic variation in atherosclerosis susceptibility?Semantic proximity Read ↗

Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.Semantic proximity Read ↗

Matrix metalloproteinases in coronary artery disease.Semantic proximity Read ↗

Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis.Semantic proximity Read ↗

Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study.Semantic proximity Read ↗

Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.Semantic proximity Read ↗

Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction.Semantic proximity Read ↗

MMP-3 polymorphism: Genetic marker in pathological processes (Review)Semantic proximity Read ↗

Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.Semantic proximity Read ↗

Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.Semantic proximity Read ↗

Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.Semantic proximity Read ↗

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.